Ovine trypanosomosis : a sero-epidemiological survey in coastal Guyana
DOI:
https://doi.org/10.19182/remvt.9398Keywords
Sheep, Trypanosoma evansi, Trypanosoma vivax, Epidemiology, Blood serum, ImmunofluorescenceAbstract
The objective of this study was to determine the seroprevalence rates of Trypanosoma vivax and Trypanosoma evansi in sheep in coastal Guyana. Blood samples were taken from a systematic random sample of one hundred and ninety-three (193) sheep on twenty-two (22) farms in Region 5, Mahaica/Berbice, a coastal area of Guyana. Age, breed, sex, and farm of origin were recorded for all sampled sheep. One hundred and seventy-six (176) serum samples were submitted for Indirect Fluorescent Antibody (IFA) testing for T. vivax and T.evansi. Fluorescence was graded as 0 (negative), 1+(very weak), 2+(weak), 3+(strong) or 4+(very strong), measured at 1:160 dilution of serum. Samples were considered to be sero-positive if any fluorescence was observed. Indirect Fluorescent Antibody results were received for one hundred and sixty-one (161) samples. One hundred and three (64 %) sera were sero-positive for Trypanosoma sp. Of these, 38 (23.6 %) sera were positive to T. evansi only, 11 (6.8 %) were positive to T. vivax only and 54 (33.5 %) were positive for both. As cross reactions occur between T. vivax and T. evansi, it was difficult to determine the true species of exposure for the sera which tested positive to both species. The overall sero-prevalence rate of 64 % suggests that trypanosomosis is endemic in sheep in coastal Guyana. This was the first serological evidence of T. evansi in Guyana. Although T. vivax is believed to be pathogenic in sheep, the clinical significance of T. evansi remains unknown. The vector of both species of trypanosomes in sheep on the north coast of South America also is not known.
Downloads
Downloads
-
Abstract435
-
PDF137
Published
How to Cite
Issue
Section
License
© S.Vokaty et al., hosted by CIRAD 1993
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.